Alnylam Pharmaceuticals, Inc. (ALNY)
224.41
+0.47
(+0.21%)
USD |
NASDAQ |
Oct 07, 16:00
220.02
-4.39
(-1.96%)
After-Hours: 05:41
Alnylam Pharmaceuticals Price : 224.41 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 224.39 | 230.42 | 222.46 | 224.41 | 1.064M |
| Oct 06, 2026 | 221.02 | 229.18 | 217.18 | 223.94 | 1.356M |
| Oct 05, 2026 | 218.36 | 222.08 | 215.46 | 219.89 | 1.281M |
| Oct 02, 2026 | 231.31 | 231.36 | 219.40 | 219.72 | 1.662M |
| Oct 01, 2026 | 248.21 | 251.71 | 230.06 | 231.18 | 2.017M |
| Sep 30, 2026 | 253.68 | 254.44 | 246.66 | 246.74 | 1.044M |
| Sep 29, 2026 | 254.86 | 257.27 | 251.02 | 254.07 | 787081.0 |
| Sep 28, 2026 | 256.28 | 256.60 | 248.12 | 255.36 | 1.148M |
| Sep 25, 2026 | 248.39 | 256.66 | 247.51 | 255.96 | 1.085M |
| Sep 24, 2026 | 246.51 | 251.81 | 245.52 | 249.59 | 933738.0 |
| Sep 23, 2026 | 249.99 | 253.81 | 245.34 | 246.51 | 1.482M |
| Sep 22, 2026 | 246.86 | 255.51 | 244.13 | 251.65 | 1.132M |
| Sep 21, 2026 | 240.37 | 247.10 | 237.96 | 244.32 | 1.153M |
| Sep 18, 2026 | 246.41 | 246.49 | 238.51 | 239.56 | 2.756M |
| Sep 17, 2026 | 242.60 | 245.63 | 239.50 | 245.51 | 1.007M |
| Sep 16, 2026 | 239.50 | 242.24 | 236.00 | 239.36 | 853903.0 |
| Sep 15, 2026 | 246.99 | 247.42 | 237.44 | 238.27 | 2.175M |
| Sep 14, 2026 | 250.16 | 252.79 | 244.18 | 249.99 | 997229.0 |
| Sep 11, 2026 | 248.05 | 254.08 | 246.01 | 248.68 | 1.177M |
| Sep 10, 2026 | 256.68 | 256.68 | 246.42 | 247.51 | 1.626M |
| Sep 09, 2026 | 257.07 | 261.98 | 253.28 | 258.00 | 1.426M |
| Sep 08, 2026 | 259.00 | 272.08 | 254.00 | 260.10 | 2.009M |
| Sep 04, 2026 | 258.58 | 266.85 | 258.02 | 266.11 | 1.431M |
| Sep 03, 2026 | 265.94 | 271.19 | 261.54 | 264.50 | 1.710M |
| Sep 02, 2026 | 246.48 | 269.94 | 246.48 | 267.40 | 3.286M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 44.16 |
| BridgeBio Pharma, Inc. | 66.50 |
| Vertex Pharmaceuticals, Inc. | 505.64 |
| Regeneron Pharmaceuticals, Inc. | 742.12 |
| Pfizer Inc. | 28.00 |
Price Related Metrics
| PE Ratio | 37.89 |
| PS Ratio | 6.424 |
| Price to Book Value | 22.16 |
| Price to Free Cash Flow | 38.87 |
| Earnings Yield | 2.64% |
| Market Cap | 30.01B |
| Operating PE Ratio | 30.87 |
| Normalized PE Ratio | 38.99 |